Submitted by Anonymous (not verified) on 11 July 2024 - 14:30
Human medicines European public assessment report (EPAR): Syfovre, pegcetacoplan, Status: Opinion under re-examination
Source:
Human medicines European public assessment report (EPAR): Syfovre, pegcetacoplan, Status: Opinion under re-examination